Serial Number 79372699
Registration 7376702
700

Registration Progress

Application Filed
Feb 10, 2023
Under Examination
Approved for Publication
Jan 31, 2024
Published for Opposition
Feb 20, 2024
Registered
May 7, 2024

Trademark Image

Basic Information

Serial Number
79372699
Registration Number
7376702
Filing Date
February 10, 2023
Registration Date
May 7, 2024
Published for Opposition
February 20, 2024
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
May 7, 2024
Registration
Registered
Classes
005

Rights Holder

ARGORNA PHARMACEUTICALS CO., LTD

99
Address
2nd and 4th Floor, Building A, 7 Suida Street,
Huangpu District, Guangzhou Guangdong
CN

Ownership History

ARGORNA PHARMACEUTICALS CO., LTD

Original Applicant
99
CN

ARGORNA PHARMACEUTICALS CO., LTD

Owner at Publication
99
CN

ARGORNA PHARMACEUTICALS CO., LTD

Original Registrant
99
CN

Legal Representation

Attorney
Victoria Friedman

USPTO Deadlines

Next Deadline
1597 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20240507)
Due Date
May 07, 2030
Grace Period Ends
November 07, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

23 events
Date Code Type Description Documents
May 7, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 7, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 4, 2024 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Mar 4, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 20, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 14, 2024 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Feb 14, 2024 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Jan 31, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 31, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 11, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 11, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 11, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 11, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 17, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
Oct 17, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
Sep 28, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Sep 28, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
Sep 18, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Sep 17, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 13, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 7, 2023 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jul 3, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 29, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; Vaccines; Biological preparations for medical purposes, for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; Medicines for human purposes; Diagnostic preparations for medical purposes; Drugs for medical purposes, namely, pharmaceuticals for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; Reagent paper for medical purposes; biochemical medicines for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia

Additional Information

Design Mark
The mark is shaped as a horizontal figue 8 with a pointed design portruding from the upper left corner, and four interwoven short lines inside the oval in the right.

Classification

International Classes
005